Silje H. Nord
Oslo, 0310, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.
Journal: Nature communications
Published: September 09, 2025
AXL-TBK1 driven AKT3 activation promotes metastasis.
Journal: Science signaling
Published: December 17, 2024
The expression of the long NEAT1_2 isoform is associated with human epidermal growth factor receptor 2-positive breast cancers.
Journal: Scientific reports
Published: September 08, 2019
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors.
Journal: Nature communications
Published: December 19, 2018
AXL Is a Driver of Stemness in Normal Mammary Gland and Breast Cancer.
Journal: iScience
Published: August 22, 2018
Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations.
Journal: Genome medicine
Published: August 14, 2018
Breast cancer quantitative proteome and proteogenomic landscape.
Journal: Nature communications
Published: May 31, 2018
Intrinsic subtypes and benefit from postmastectomy radiotherapy in node-positive premenopausal breast cancer patients who received adjuvant chemotherapy - results from two independent randomized trials.
Journal: Acta oncologica (Stockholm, Sweden)
Published: November 28, 2017
The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 19, 2017
Last Updated: 09/26/2026